Abstract
dc:description.abstractMyelin is a lipid-rich substance produced by cells called oligodendrocytes which surrounds axons in the central nervous system (CNS). Myelin plays critical roles in the CNS, including facilitating fast action potential propagation and maintaining axonal health and integrity. The loss of myelin from axons is known as demyelination. Demyelination is a feature of a range of conditions including Multiple Sclerosis, leukodystrophies, white matter stroke, and traumatic CNS injury. While the complete loss of myelin is known to be detrimental to CNS function, the process by which myelin breaks down, prior to its loss, has remained less well explored. Myelin is an extremely complex structure, and consists of concentric wraps of membrane surrounding, and tightly adhered to, axons. It is likely, then, that the mechanisms involved in removal of myelin from the axon may be very detrimental for both structures. Owing to the highly ordered structure of the myelin sheath, demyelination may even consist of features common across different causes of damage. In this project, I aimed to investigate the earliest features of demyelination and the acute consequences for axonal structure. I used transgenic reporters to image myelin and axons by confocal microscopy in the zebrafish spinal cord. I first characterised myelin sheath damage in two demyelination models, one induced by oligodendrocyte damage or death (caused by activation of the nitroreductase enzyme in myelinating cells, or the mbp:NTR model), the other by cation-induced damage to myelin sheaths (via activation of the rat transient receptor potential V1 in myelinating cells, or the mbp:TRPV1 model). Myelin sheath damage in both models led to myelin swelling, which occurred before complete sheath loss when analysed by live imaging. Myelin sheath damage in the mbp:NTR model predominantly involved the formation of myelin vacuoles, large fluid-filled swellings within the myelin sheath. Myelin sheath damage in the mbp:TRPV1 model predominantly involved myelin vesiculation, the transformation of myelin layers into de-compacted vesicles. I compared these models to fixed tissue from a rodent, immune-mediated demyelination model known as Experimental Autoimmune Encephalomyelitis (EAE). Myelin vacuolation was also evident in rodent EAE following analysis of toluidine blue-stained spinal cord sections. Examination of the existing literature indicated that both of these features of myelin damage may in fact be very common across a range of demyelination models. Having seen that demyelination in these models did not simply involve the rapid loss of the sheath from the axon, but instead involved a disruptive phase of myelin damage, I next asked how this process affected axon structure acutely. Myelin damage in both models was associated with structural changes to axons. Axons were significantly more distorted and displayed fewer normal-appearing synaptic boutons following induction of myelin damage, compared to controls. Together, these data suggest that the process of demyelination itself may be detrimental to axon structure at very early stages. I next investigated if either myelin or axon damage in these demyelination models could be mitigated. In contexts outside of typical demyelination models, swelling of myelin has previously been observed when CNS ion and fluid homeostasis associated with neuronal activity have been disrupted. I hypothesised that this might also play a role in driving myelin damage during demyelination. In the mbp:NTR model, reducing neuronal activity with a voltage-gated sodium channel blocker could mitigate myelin vacuolation, whereas increasing neuronal activity with a GABA-A receptor antagonist could exacerbate myelin vacuolation. Furthermore, in the mbp:TRPV1 model, treatment of animals with a voltage-gated sodium channel blocker or a GABA-A receptor antagonist mitigated and exacerbated axonal distortion, respectively. Together these data suggest that ion homeostasis in the CNS may play a role in regulating both myelin and axonal damage during demyelination. Since myelin damage could be prevented or mitigated, I next wondered if it might also be reversible. Surprisingly, I saw that following mild myelin damage, sheaths were often significantly morphologically altered, but not lost. This suggests myelin sheaths have the capacity to adapt to being damaged, without always being lost, or demyelinated. In summary, this research highlights the complexity of the process of demyelination, but also suggests that features of demyelination may be common across different models. It also indicates that axons can be rapidly affected by myelin damage, even prior to complete demyelination. Using the power of zebrafish for live imaging, I saw that demyelination was not always inevitable following myelin damage, particularly if the initial damage was not very severe. Together, this suggests that demyelination itself may be a regulatable, cell biological process, one that we may in future be able to manipulate to preserve myelin and axons in disease.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Arafa, Donia
- Advisors dc:contributor.advisor
-
- Lyons, David
- Williams, Anna
- Miron, Veronique
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/4564